Survey of Canadian Radiation Oncologists on Stage I Testicular Seminoma Management
Author Information
Author(s): Samant R. MD, Alomary I. MD, Genest P. MD, Eapen L. MD
Primary Institution: The Ottawa Hospital Cancer Centre
Hypothesis
How do Canadian radiation oncologists currently manage stage I testicular seminoma patients?
Conclusion
Canadian radiation oncologists are increasingly favoring surveillance over adjuvant radiotherapy for managing stage I testicular seminoma.
Supporting Evidence
- Adjuvant radiation is considered by 90% of respondents, but surveillance is chosen by 56% as the most appropriate management.
- 30% of respondents listed adjuvant chemotherapy as a standard treatment option.
- Most respondents (91%) discuss surveillance with patients.
Takeaway
Doctors in Canada are talking more about watching patients closely instead of using radiation after surgery for testicular cancer.
Methodology
An electronic survey was sent to Canadian radiation oncologists to assess their management practices for stage I testicular seminoma.
Potential Biases
Potential bias due to self-reported data and non-response from some oncologists.
Limitations
The survey may not fully represent all Canadian radiation oncologists as some did not respond.
Participant Demographics
89% male, 11% female, median age 43 years, mean length of practice 13 years, 80% in academic centers.
Statistical Information
P-Value
0.07
Statistical Significance
p=0.07
Want to read the original?
Access the complete publication on the publisher's website